L. Roshchyna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
L. Roshchyna has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- O. I. Dronov
Bogomolets National Medical University, Kyiv
2 shared publications - I. O. Kovalska
Bogomolets National Medical University, Kyiv, Ukraine
1 shared publication - Liudmyla Levchenko
Bogomolets National Medical University, Kyiv
1 shared publication - T. Ivanets
Bogomolets National Medical University, Kyiv, Ukraine
1 shared publication - V. I. Nahrebetskyi
Bogomolets National Medical University, Kyiv
1 shared publication - Yu. P. Bakunets
O. O. Bogomolets National Medical University, Kyiv
1 shared publication
Latest Publications
- Open Access
- 31 July 2025
- Published by Publishing Company VIT-A-POL in General Surgery
- No. 2,p. 56-61
Clinical approach to the treatment of metastatic skin melanoma. Сase study
Melanoma is an aggressive disease that accounts for approximately 75% of skin cancer‑related deaths. The primary objectives of surgery in metastatic disease are symptom relief and debulking. As effective systemic treatment prolongs survival in a patient population with advanced disease, the role of local palliative therapy potentially increases. When considering palliative surgery, it is crucial to weigh the potential risks of surgical complications against the burden caused by the symptomatic lesions. We present a case report of melanoma TхNхM1c metastasis to the skin in the right supraclavicular area with disintegration and bleeding, metastatic lesions in the cervical, axillary, and subpectoral lymph nodes bilaterally, and metastatic lesions in the left adrenal gland, stage IV. The patient was urgently hospitalized with manifestations of diffuse bleeding associated with tumor disintegration. According to the treatment history, the patient has been receiving targeted chemo‑immunotherapy since 2022. The pain syndrome intensified, and periodic episodes of bleeding from the tumor were observed. Сytoreductive surgery tactics were discussed by the multidisciplinary team and agreed upon with the patient. Тhe patient insisted on removing the tumor despite the risks of the operation. This clinical study deals with a controversial, yet clinically required, palliative care method for preserving and improving the quality of life with this diagnosis. This case highlights the aggressive nature of generalized melanosis, characterized by a rapid clinical course and limited response to traditional targeted chemo‑immunotherapy. The difficulties encountered in the diagnosis and treatment of this aggressive form of metastatic melanoma underscore the need for early detection, tailored therapeutic approaches, and ongoing research efforts to improve treatment outcomes in such cases.
- 31 July 2025
- Published by Publishing Company VIT-A-POL in General Surgery
- No. 2,p. 56-61
Open AccessClinical approach to the treatment of metastatic skin melanoma. Сase study
Melanoma is an aggressive disease that accounts for approximately 75% of skin cancer‑related deaths. The primary objectives of surgery in metastatic disease are symptom relief and debulking. As effective systemic treatment prolongs survival in a patient population with advanced disease, the role of local palliative therapy potentially increases. When considering palliative surgery, it is crucial to weigh the potential risks of surgical complications against the burden caused by the symptomatic lesions. We present a case report of melanoma TхNхM1c metastasis to the skin in the right supraclavicular area with disintegration and bleeding, metastatic lesions in the cervical, axillary, and subpectoral lymph nodes bilaterally, and metastatic lesions in the left adrenal gland, stage IV. The patient was urgently hospitalized with manifestations of diffuse bleeding associated with tumor disintegration. According to the treatment history, the patient has been receiving targeted chemo‑immunotherapy since 2022. The pain syndrome intensified, and periodic episodes of bleeding from the tumor were observed. Сytoreductive surgery tactics were discussed by the multidisciplinary team and agreed upon with the patient. Тhe patient insisted on removing the tumor despite the risks of the operation. This clinical study deals with a controversial, yet clinically required, palliative care method for preserving and improving the quality of life with this diagnosis. This case highlights the aggressive nature of generalized melanosis, characterized by a rapid clinical course and limited response to traditional targeted chemo‑immunotherapy. The difficulties encountered in the diagnosis and treatment of this aggressive form of metastatic melanoma underscore the need for early detection, tailored therapeutic approaches, and ongoing research efforts to improve treatment outcomes in such cases.
- Open Access
- 30 November 2023
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 19 (7) , 471-477
Risk factors for pancreatic necrosis in acute pancreatitis in obese patients
Background. Acute pancreatitis is an aseptic inflammation of the pancreas with diverse complications and further development of necrosis of the gland, parapancreatic tissue and possible addition of secondary infection. A significant number of biochemical markers that can be predictors of pancreatitis complications are still being researched. However, most of them are expensive and their indicators are increased only in the first 24–48 hours after the onset of the disease, so they are not used in daily clinical routine. The purpose of this study is to evaluate the factors that indicate an elevated risk of necrosis in acute severe pancreatitis. Materials and methods. A retrospective analysis of 80 patients with acute pancreatitis was performed via creation of a multivariate logistic regression model. Results. The dependence of the risk of pancreatic necrosis on the following factor signs was found: lipase at the onset of the disease (cut-off value = 599.6 U/l, area under the receiver operating characteristic curve (АUС) = 0.72 (95% confidence interval (СІ) 0.57–0.88)), severity of the disease, fibrinogen on day 3 of the disease (cut-off value = 9.7, АUС = 0.65 (95% СІ 0.48–0.81)), C-reactive protein (cut-off value = 175.7 mg/L, AUC = 0.70 (95% CI 0.54–0.86)), and intra-abdominal mean capillary perfusion pressure on the first day of the disease (cut-off value ≤ 63.3 mm Hg, АUС = 0.88 (95% СІ 0.77–0.99)). The autopsy results revealed the presence of necrosis and microthrombosis of the pancreas. Conclusions. Factors that may indicate an increased risk of pancreatic necrosis were high levels of lipase, fibrinogen on the third day of the disease, C-reactive protein, decreased intra-abdominal mean capillary perfusion pressure, severity of the disease, and the presence of portosplenomesentric thrombosis.
- 30 November 2023
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 19 (7) , 471-477
Open AccessRisk factors for pancreatic necrosis in acute pancreatitis in obese patients
Background. Acute pancreatitis is an aseptic inflammation of the pancreas with diverse complications and further development of necrosis of the gland, parapancreatic tissue and possible addition of secondary infection. A significant number of biochemical markers that can be predictors of pancreatitis complications are still being researched. However, most of them are expensive and their indicators are increased only in the first 24–48 hours after the onset of the disease, so they are not used in daily clinical routine. The purpose of this study is to evaluate the factors that indicate an elevated risk of necrosis in acute severe pancreatitis. Materials and methods. A retrospective analysis of 80 patients with acute pancreatitis was performed via creation of a multivariate logistic regression model. Results. The dependence of the risk of pancreatic necrosis on the following factor signs was found: lipase at the onset of the disease (cut-off value = 599.6 U/l, area under the receiver operating characteristic curve (АUС) = 0.72 (95% confidence interval (СІ) 0.57–0.88)), severity of the disease, fibrinogen on day 3 of the disease (cut-off value = 9.7, АUС = 0.65 (95% СІ 0.48–0.81)), C-reactive protein (cut-off value = 175.7 mg/L, AUC = 0.70 (95% CI 0.54–0.86)), and intra-abdominal mean capillary perfusion pressure on the first day of the disease (cut-off value ≤ 63.3 mm Hg, АUС = 0.88 (95% СІ 0.77–0.99)). The autopsy results revealed the presence of necrosis and microthrombosis of the pancreas. Conclusions. Factors that may indicate an increased risk of pancreatic necrosis were high levels of lipase, fibrinogen on the third day of the disease, C-reactive protein, decreased intra-abdominal mean capillary perfusion pressure, severity of the disease, and the presence of portosplenomesentric thrombosis.